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Fluoroquinolone-
resistant
Salmonella sp. in
Carcasses 
To the Editor: Fluoroquinolone
(FQ)-resistant  Salmonella has been
isolated from patients in Taiwan
(1–7). Recently, a report further indi-
cated that several patients were infect-
ed with Salmonella enterica serovar
Schwarzengrund with high-level FQ
resistance (1). S. Schwarzengrund has
never been isolated from food animals
in Taiwan. 
We report the isolation of FQ-
resistant strains from pork and broiler
carcasses sampled from 2000 to 2003:
27 in 2000, 3 in 2001, 4 in 2002, and
2 in 2003. These isolates made up
18.85% of the 191 Salmonella strains
obtained from pork and broiler car-
casses in the study period. Of these
isolates, 16 FQ-resistant S.
Schwarzengrund strains were further
analyzed to elucidate the possible
mechanism of FQ resistance.
Ciprofloxacin MIC levels in these iso-
lates ranged from 4 to 16 µg/mL, and
all had high-level nalidixic acid resist-
ance (>1,024 µg/mL). All of the 16
investigated strains displayed muta-
tions possibly associated with high-
level FQ resistance. The mutation
sites included 2 sites (Ser83Phe and
Asp87Gly) in the quinolone resist-
ance–determining region (QRDR) of
gyrA, 2 sites (Thr57Ser and
Ser80Arg) in the QRDR of parC, and
1 site (Ser458Pro) in the QRDR of
parE, respectively. Four strains had
mutations in the QRDR of gyrA and
parC only but not in the QRDR of
parE (Table).
In conclusion, high-level FQ
resistance was detected in S.
Schwarzengrund isolated from pork
and chicken in Taiwan. Specific muta-
tion sites of gyrA,  parC, and  parE
were associated with high-level FQ
resistance in all the isolates investi-
gated. Our results warrant further
investigation of the public health con-
sequences of FQ use in food animals
in Taiwan.
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Cocirculation of
Dengue Serotypes,
Delhi, India, 2003 
To the Editor: Delhi, in the north-
ern part of India, has had outbreaks of
dengue caused by various dengue
virus types in 1967, 1970, 1982, 1988,
and 1996 (1–5). In 1988, for the first
time, a few cases of dengue hemor-
rhagic fever (DHF) were seen (4).
Subsequently, we reported the largest
outbreak of DHF/dengue shock syn-
drome (DSS) in Delhi in 1996 and
confirmed dengue virus type 2 as the
etiologic agent (5). 
We report the results of virologic
testing of samples received at the All
India Institute of Medical Sciences
from patients with suspected dengue
fever or denguelike illness from Delhi
and its adjoining areas during a 2003
outbreak of dengue. According to the
World Health Organization (6), 2,185
laboratory-confirmed cases were
reported during this outbreak. 
Of the blood samples received by
the virology laboratory, 42 were
received on ice from patients with
acute denguelike illness. Serum was
separated aseptically and stored at
–70°C. The standard method of virus
cultivation, which used the C6/36
clone of the Aedes albopictus cell line,
was followed with some modifications
(7). On days 5 and 10, harvested cells
were tested by an indirect immunoflu-
orescence assay (IFA) using mono-
clonal antibodies to dengue virus types
1–4 (provided by the Centers for
Disease Control and Prevention,
Atlanta, Georgia, USA, during the
1996 outbreak). If IFA results were
negative for dengue viruses on first
passage, a second passage was made,
and cells were again harvested on days
5 and 10 for IFA. The 4 dengue virus
types (obtained from the National
Institute of Virology, Pune, India)
were included as positive controls, and
uninfected C6/36 cells were kept as
negative controls. 
Dengue virus could be isolated in
C6/36 cells from 8 (19%) of 42 sam-
ples processed for virus isolation
(Table). Of the 8 isolates, two each
were identified as dengue virus types
1 and 2, three as type 3, and one as
type 4. All but one isolate were from
patients with uncomplicated dengue
fever. One dengue type 2 isolate was
obtained from a 7-year-old boy with
secondary dengue infection and
DHF/DSS. The ages of culture-posi-
tive patients ranged from 5 to 62
years, with a median of 22 years.
These patients were equally distrib-
uted between children (<12 years) and
adults. The male-to-female ratio for
these 8 patients was 5:3. The duration
of fever at the time of viral isolation
was 1–5 days, with a median of 3
days. 
All previous outbreaks in Delhi
have occurred during the monsoon
(rainy) season between August and
November and subsided with the
onset of winter. We recently reported
the results of serologic testing during
the 2003 outbreak, which also
occurred from September to
November, with a peak in mid-
October 2003 (8). This outbreak was
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